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1612Contribution of HLA-A/B/C/DRB1/DQB1 Common
Haplotypes to Donor Search Outcome in Unrelated
Hematopoietic Stem Cell Transplantation
Beatrice Pedron,1 Valerie Guerin-El Khourouj,1 Jean-Hugues Dalle,2
Marie Ouachee-Chardin,2 Karima Yakouben,2 France Corroyez,2 Anne Auvrignon,4
Arnaud Petit,4 Judith Landman-Parker,4 Guy Leverger,4 Andre Baruchel,2,3 Ghislaine Sterkers1In unrelated hematopoietic stem cell transplantation (HSCT), the prediction of donor search outcome at the
time of search initiation is of great value for the physicians to delineate the strategy of patient care. The prob-
ability of finding an unrelated donor is high for patients who carry at least 1 of the 10 most common HLA
haplotypes in Caucasians. As only 10% to 20% patients respond to this criterion, here we aimed at finding
additional common haplotypes to improve the prediction of a successful search. HLA broad HLA-A/B/
DRB1 haplotypes that were observed with frequencies $0.19% in patient families of European origin and
that split into #2 predominant 4-digit HLA-A/B/C/DRB1/DQB1 haplotypes were considered as common.
Carriage of at least 1 of those in 168 patients of various geographic areas with no family donor was con-
fronted to the chance of finding $9/10 HLA-matched unrelated donors. Fifty common 4-digit haplotypes
were identified. A higher (P \ 5  1026) chance of finding a suitable donor was found for 55 of 170
(32%) recipients that carried at least 1 of these common haplotypes. Up to now, estimates classified patients
into$3 groups of probability with$1 intermediate group of poor utility for the clinicians. Considering car-
riage of these common haplotypes together with the frequencies of alleles and of B/C and DRB1/DQB1 as-
sociations, which are carried by patient HLA haplotypes, we could classify the patients into 2 groups of
probability with a 98% and 26% chance of finding a donor, respectively. Prediction of search outcome could
be improved by including the 50 most common HLA haplotypes in the current approaches.
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6/j.bbmt.2011.03.009inborn errors of metabolism. HLA genotypically iden-
tical siblings are preferred as donors because the inher-
itance of identical MHC haplotypes by descent
includes identity for all variations within the 2 parental
haplotypes. UnrelatedHSCT fromHLA-matched do-
nors can be an alternative when a related donor is not
available [1-3].
Allele compatibility for HLA-A/B/C/DRB1/DQB1
definedas a10/10matchor as a secondchoicewithonly1
mismatch, defined as a 9/10 match, are the current stan-
dards required for most transplant centers [4-10].
Because of an extensive polymorphism of the HLA
system and despite the impressive number of HSCT
donors worldwide, no donor responds to these criteria
for 20% to 40% of European or North American
patients and for up to 90% of patients from minority
ethnic groups [4,11,12].
At the time of search initiation, the prediction of
donor search outcome is of great value for the physi-
cians to delineate the strategy of patient care. Indeed,
rapid conventional therapy or alternative HSCT, such
as cord blood or haploidentical HSCT, are preferable
Biol Blood Marrow Transplant 17:1612-1618, 2011 1613Estimate of Unrelated Donor Search Outcometo prolonged and plausible search in vain [13-17]. This
prediction is limitedbecause only low-resolutionHLA-
A, -B, and -DRB1 typings of most registry donors are
available to remain cost effective, although approxi-
mately 50% of the HLA-A/B/DRB1 low-resolution
matched donors will be definitely HLA matched after
high-resolution confirmatory typing [12].
The duration and success rate of an unrelated do-
nor search greatly depends on patients’ HLA typings.
Currently, patients carrying at least 1 of the well-
known 10 most frequent Caucasian HLA haplotypes
have the highest chances of identifying HLA allele
matched donors within few weeks [18-20]. Only 10%
to 20% of Caucasian patients carry such haplotypes.
For the remaining patients, common alleles and
common HLA-B/C and HLA-DRB1/DQB1 asso-
ciations are mostly used to identify patients with
a high chance of successful donor search [18,21].
Less common alleles, when carried by haplotypes
with sufficient frequency, do not preclude however
the possibility of finding a donor [19]. Based on this as-
sumption, this study aimed at identifying additional
common haplotypes in Caucasians of European origin,
who largely contribute to Bone Marrow Donor
Worldwide (BMDW) registries, to improve the pre-
diction of a successful search.
The estimation strategy did not always apply to
minority ethnic groups because of distinct frequencies
of alleles and of associations from 1 geographic area to
another. In our region, 2 Caucasian groups predomi-
nate: first, European Caucasians (EuC) and second,
North African Caucasians (NAC). The interest in us-
ing additional common haplotypes to estimate search
outcome was analyzed comparatively in the 2 groups.MATERIALS AND METHODS
Population
Typing results from 774 families of pediatric pa-
tients awaiting an HSCT donor (performed from
January 1999 to December 2009) were initially exam-
ined. One selection criterion for subsequent inclusion
wasHLA-haplotype assignment with certainty by fam-
ily segregation analysis. Another selection criterionwas
clear documentation of the geographic origin of fami-
lies. In total, 1996Caucasian haplotypes from 522 fam-
ilies responding to these criteria were selected. A total
of 1602 haplotypes were carried by EuC and 394 by
NAC. All individuals were born and lived in France.HLATyping
Broad HLA typing was performed by serologic
and/or low-resolution typing at first line, followed
by high-resolution typings when required for unre-
lated donor searches. Serologic typing was performed
for HLA-A and B testing by microlymphocytotoxicity(Labtype One Lambda, Canoga Park, CA). All HLA-
A and -B specificities described in the WHO nomen-
clature report were differentiated by serology. The
specificities HLA-A69, A74, A80, B45, B49, B50,
B65, B71, B46, B47, B48, B67, B73, B76, B77, and
B78 were confirmed by completing serology with
polymerase chain reaction-based sequence-specific ol-
igonucleotide hybridization (PCR-SSO) (see below).
Low-resolution typing of A, B (when required), and
of HLA-C, DRB,1 and DQB1 were performed by
PCR-SSO by using the commercial kits (Innolipa, Ab-
bot France, S.A. Rungis, France; Labtype One
Lambda) in any recipient and family members.
In the case of an unrelated donor search, high-
resolution typing was subsequently performed in
the patient by polymerase chain reaction sequence-
specific primers (PCR-SSP) (Olerup SSP subtype,
Genovision, Monfort L’Amaury France) for A, B,
C, and DRB1 loci or by PCR-SSO (Labtype One
Lambda) for DQB1 locus. Occasionally, when re-
quired, high-resolution typing was completed by
Sequence-based typing in the Strasbourg, France,
lab according to the lab’s local procedure.Haplotype Assignment
Haplotypes were assigned by the mode of inheri-
tance after examination of HLA typings in the patient
and the 2 parents.Procedure of Unrelated Donor Search
For patients with no suitable family donor, our
strategy is to search for $9/10 HLA-matched
unrelated donors in BMDW registries.
With the exception of finding a suitable donor
already subtyped, 5 blood samples from $5/6
HLA-A/B/DR matched donors from western Euro-
pean and North American registries were asked for
complementary genomic typing in our lab, with pri-
ority to donors with available DRB1 high-resolution
typing. In the case of uncommon B/C and/or
DRB1/DQB1 association for the patient, our strat-
egy consisted of requesting the blood samples of
donors already typed for C and/or DQB1 locus.
Matching criteria for the selection of donors were
10 HLA alleles matched at sequence level (A*, B*,
C*, DRB1*, and DQB1*) or at a second choice
only one mismatch at locus A*, B*, C*, or DQB1*.Statistical Analysis
The Fisher exact test was used for comparison
between groups. P \ .05 was considered
significant.
Table 1. Listing of Common Haplotypes
A-B-DRB1 Broad Haplotypes id
EuC
(n 5 1602)
F(%)*
NAC
(n 5 394)
F(%)*
Common 4-digit Haplotypes
id
n/n0 in
EuC†
n/n0 in
NAC Mismatches‡A* B* C* DRB1* DQB1*
A1-B8-DR17 1 4.18 1.02 01:01 08:01 07:01 03:01 02:01 1.1 29/29 4/4
A29-B44-DR7 2 2.68 0.51 29:02 44:03 16:01 07:01 02:02 2.1 15/15 1/1
A3-B7-DR15 3 1.81 0.76 03:01 07:02 07:02 15:01 06:02 3.1 7/7 1/1
A2-B7-DR15 4 1.25 0.76 02:01 07:02 07:02 15:01 06:02 4.1 5/5 2/2
A2-B44-DR4 5 1.25 1.52 02:01 44:02 05:01 04:01 03:01 5.1 6/8 0 DQB1*03:02, DRB1*04:04
A2-B62-DR4 6 1.06 0 02:01 15:01 03:04 04:01 03:02 6.1 5/11 0 C*01:03, C*03:03
02:01 15:01 03:03 04:01 03:02 6.2 4/11 0 DRB1*04:04/07
A2-B44-DR7 7 1.06 0 02:01 44:03 16:01 07:01 02:02 7.1 4/6 0 A*02:17, B*44:05/C*02:02
A23-B44-DR7 8 1.00 0 23:01 44:03 04:01 07:01 02:02 8.1 4/4 0
A11-B35-DR1 9 0.94 0 11:01 35:01 04:01 01:01 05:01 9.1 4/9 0
11:01 35:01 04:01 01:03 05:01 9.2 5/9 0
A3-B35-DR1 10 0.87 0 03:01 35:01 04:01 01:01 05:01 10.1 5/5 0
A24-B7-DR15 11 0.81 0 24:02 07:02 07:02 15:01 06:02 11.1 5/6 0 C*07:18
A33-B65-DR1 12 0.75 0 33:01 14:02 08:02 01:02 05:01 12.1 5/6 0 A*33:05
A30-B13-DR7 13 0.62 0.25 30:01 13:02 06:02 07:01 02:02 13.1 5/5 1/1
A2-B18-DR11 14 0.56 0.25 02:01 18:01 07:01 11:04 03:01 14.1 4/7 1/1 C*03:04/07:04/01:02, DRB1*11:01
A2-B8-DR17 15 0.50 0.76 02:01 08:01 07:01 03:01 02:01 15.1 3/3 1/3 C*07:02, A*02:11
A3-B7-DR1 16 0.50 0.25 03:01 07:02 07:02 01:01 05:01 16.1 3/3 1/1
A30-B18-DR17 17 0.50 1.27 30:02 18:01 05:01 03:01 02:01 17.1 3/3 2/3 DRB1*03:05
A1-B7-DR15 18 0.50 0 01:01 07:02 07:02 15:01 06:02 18.1 3/3 0
A1-B8-DR4 19 0.50 0 01:01 08:01 07:01 04:01 03:01 19.1 3/8 0 DRB1*04:02/05
01:01 08:01 07:01 04:01 03:02 19.2 3/8 0
A2-B44-DR11 20 0.50 0 02:01 44:02 05:01 11:01 03:01 20.1 3/6 0 B*44:04, DRB1*11:02, C*16:01
A2-B57-DR7 21 0.50 0 02:01 57:01 06:02 07:01 03:03 21.1 5/6 0 C*07:01, DQB1*02:02
A68-B53-DR13 22 0.44 0.51 68:02 53:01 04:01 13:02 06:04 22.1 3/4 2/2 DRB1*13:03/DQB1*02:02
A2-B51-DR8 23 0.44 0 02:01 51:01 14:02 08:01 04:02 23.1 3/5 0 DRB1*08:03/DQB1*03:01 C*15:02
A2-B60-DR13 24 0.44 0 02:01 40:01 03:04 13:01 06:03 24.1 2/6 0
02:01 40:01 03:04 13:02 06:04 24.2 4/6 0
A25-B18-DR15 25 0.37 0 25:01 18:01 12:03 15:01 06:02 25.1 3/3 0
A31-B60-DR4 26 0.37 0 31:01 40:01 03:04 04:04 03:02 26.1 3/3 0
A2-B50-DR7 27 0.37 0.76 02:01 50:01 06:02 07:01 02:02 27.1 2/6 1/3 A*02:27, A*02:04
02:05 50:01 06:02 07:01 02:02 27.2 3/6 1/3
A2-B35-DR13 28 0.37 0.25 02:01 35:01 04:01 13:01 06:03 28.1 2/3 0/1 C*14:02,DRB1*13:02, DQB1*06:04, B*35:08
A11-B52-DR15 29 0.31 0.51 11:01 52:01 12:02 15:02 06:01 29.1 4/4 2/2
A24-B8-DR17 30 0.31 1.02 24:02 08:01 07:01 03:01 02:01 30.1 3/3 2/3 C*07:02
A29-B44-DR15 31 0.31 0.51 29:02 44:03 16:01 15:01 06:02 31.1 4/4 1/2 DRB1*15:02 DQB1*06:01
A1-B8-DR13 32 0.31 0 01:01 08:01 07:01 13:01 06:03 32.1 3/3 0
A1-B8-DR15 33 0.31 0.25 01:01 08:01 07:01 15:01 06:02 33.1 3/3 0/1 DRB1*15:02 DQB1*06:01
A2-B27-DR1 34 0.31 0.51 02:01 27:05 01:02 01:01 05:01 34.1 2/4 2/2 C*02:02 DRB1*01:03
A23-B49-DR11 35 0.25 0.76 23:01 49:01 07:01 11:01 03:01 35.1 4/4 1/3 DRB1*11:02/04
A3-B35-DR15 36 0.25 0 03:01 35:01 04:01 15:01 06:02 36.1 2/3 0 C*07:02
A11-B7-DR15 37 0.25 0 11:01 07:02 07:02 15:01 06:02 37.1 3/3 0
A1-B52-DR15 38 0.25 0.76 01:01 52:01 12:02 15:02 06:01 38.1 3/3 1/2 DRB1*15:01
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Listing of Common Haplotypes in Caucasians
of European Origin
In this study, haplotypes were arbitrarily and pro-
spectively defined as common when found in at least 3
unrelated families of European origin based on the
assumption that these haplotypes could be easily ob-
served in donors from European and North American
registries. Among 1602 HLA-A/B/DRB1 broad hap-
lotypes that were precisely assigned by the mode of in-
heritance in 420 family donors of EuC origin, 70,
which were found in $3 families, were considered as
common (corresponding to haplotype frequency:
F $ 0.19%). Subtyping results from these 70 haplo-
types revealed that 25 split into$3 4-digit haplotypes.
These were not further analyzed. Among the 45 re-
maining haplotypes, 40 evidenced a homogeneous or
1 predominant subtyping, and 5 split each into 2
predominant 4-digit haplotypes with equilibrated dis-
tribution. These 45 broad haplotypes leading to 50
4-digit haplotypes were qualified common broad and
common 4-digit haplotypes, respectively. Table 1 lists
the 45 broad and the 50 4-digit common haplotypes
together with their distribution within the European
(EuC) families.
As expected, the 10 most common broad haplo-
types that are well known in Caucasians from Euro-
pean and North American origins were found at high
frequency in EuC (identification number 1-6, 10, 15,
24, and 45 in bold in Table 1). A total of 8 of 10 gave
rise to a homogeneous subtyping (identification num-
bers 1-5, 10, 15, and 45), and 2 gave rise each to 2
4-digit haplotypes with equilibrated distributions
(identification numbers 6 and 24).
With regard to the 35 additional common broad
haplotypes, 32 of 35 gave rise to 1 predominant 4-digit
haplotype and 3 of 35 gave rise each to 2 4-digit hap-
lotypes with equilibrated distribution.
Note that mismatches that distinguished 4-digit
common haplotypes from less common haplotypes
(right column in bold, Table 1) mostly involved the
HLA-DRB1 and -DQB1 loci and, to a lesser extent,
the HLA-C .HLA-B and HLA–A loci.Common Haplotypes in EuC Are Less
Frequently Observed in NAC
The distribution of common haplotypes within pa-
tient families of NAC origin is also shown in Table 1.
Broad haplotypes common inEuCwere less frequently
observed in NAC, although both NAC and EuC are of
Caucasian origin (14.69% and 29.39%, respectively).
Moreover, subtypings revealed even less frequent
carriage of common 4-digit haplotypes inNAC. Again,
differences in typings between EuC and NAC
were mostly confined to the HLA-DRB1/DQB1
Table 3. Frequent Alleles*
HLA-A HLA-B HLA-DRB1
01:01 07:02 01:01
02:01 08:01 01:02
03:01 13:02 03:01
11:01 14:01 04:01
23:01 14:02 04:02
24:02 15:01 04:05
25:01 15:03 07:01
26:01 15:10 08:01
29:01 18:01 09:01
29:02 27:05 10:01
30:01 35:01 11:01
30:02 37:01 11:04
31:01 38:01 12:01
32:01 39:01 13:01
33:01 40:01 13:02
34:02 40:02 14:01
36:01 40:06 14:54
66:01 41:02 15:01
68:01 44:02 15:02
68:02 44:03 16:01
69:01 45:01
74:01 47:01
80:01 49:01
50:01
50:02
51:01
52:01
53:01
55:01
56:01
57:01
58:01
The rationale for this selection is based on their association with a high
probability of finding a donor in our center (not shown).
*Frequent alleles are defined as the one or the two predominant alleles
within a serologic specificity for all specificities but the 3 most frequent
alleles within the DR4 specificity.
1616 Biol Blood Marrow Transplant 17:1612-1618, 2011B. Pedron et al.haplotypes and to the HLA-C locus (right column in
italic, Table 1).
Carriage of at Least 1 4-Digit Common
Haplotype by Recipients Enhanced
the Probability of Finding a Suitable Donor
A $9/10 HLA-matched unrelated donor was
searched for 168 patients of various geographic origins
(95 EuC, 27 NAC, 18 Black/Africans, 10 Asians, 5
mixed, and 13 of other origin) from February 2006
to September 2010. Carriage of at least 1 of the com-
mon 4-digit haplotypes listed in Table 1 had a positive
impact on donor search outcome (P \ 5  1026)
(Table 2).
Indeed, a donor was found for 52 of 55 (94%) pa-
tients with$1 4-digit common haplotypes but in 70 of
115 (61%) without these haplotypes. Of note, the 3 pa-
tients with 1 common haplotype but no donor found
had a non-Caucasian origin, that is, from Caribbean
(n 5 1) or from Reunion Island (n 5 2) and #3
HLA-A/B/DR broadly identical donors in BMDW
registries.
The Use of the 50 Common 4-Digit Haplotypes
Identified in This Study in the Current Process
of Estimate Improves the Prediction of Donor
Search Outcome
We previously classified patients awaiting an
HSCT into 3 groups, that is, a high, an intermedi-
ate, and a low probability group, respectively, based
on allele frequencies listed in Table 3 and on the
frequencies of B/C and DRB1/DQB1 associations
that were listed in a previous study [22]. The inter-
mediate probability group that included about 30%
of patients waiting for an unrelated donor was of
poor utility for the physicians as about one-half of
the patients from this group will have a donor
found and one-half will not. We assessed whether
including the 50 common 4-digit haplotypes in
the prediction process could allow a classification
into 2 groups, that is, a high and a low probability
group. Patients were assigned to a high probability
group when they carried (1) at least 1 common
4-digit haplotype but no more than 2 rare alleles
or unusual B/C or DRB1/DQB1 association on the
second haplotype or (2) no common 4-digit haplotypeTable 2. Probability of Finding $9/10 HLA-Matched Donors
Related to Common 4-Digit Haplotype Expression in Patients
Recipients with at Least
One Common
Haplotype (n)
Recipients without
Common
Haplotype (n)
Recipients with suitable
donor identified (n)
52 70
Recipients without suitable
donor identified (n)
3 45
Success of search (%) 94 61and no more than 1 rare allele or rare B/C or DRB1/
DQB1 association on the 2 haplotypes. The remaining
patients as well as the patients with#3 HLA-A/B/DR
broadly matched donors in the BMDW registries were
assigned to a low probability group. As shown in Table
4, this procedure was highly efficient to predict the
chance of finding a $9/10 HLA-matched donor in
our center. Of note, 95 of 168 (56%) patients who
were analyzed were of European origin, although
44% were not.DISCUSSION
Tron de Bouchony et al. [23] first reported that pa-
tients with at least 1 of the 10 most common haplo-
types have a high probability of a successful donor
search. The relevance of common HLA-A/B/DRB1
haplotypes to success rates of unrelated donor search,
based on these broad matches between donors and
recipients has been subsequently reported by others
[18-20,23,24]. Of course, our results are in line with
these previous observations. They also showed that 8
of 10 most common A/B/DRB1 haplotypes gave rise
to homogeneous subtypings, whereas 2 of 10 gave
Table 4. Search Outcome in the High and Low Probability
Groups
High Low
Recipients with $9/10 HLA-matched
donors (n)
104* 16
Recipients with no $9/10 HLA-
matched donors (n)
2 46
Success of search % 98 26
*A total of 65/104 (62.5%) had a 10/10 HLA matched donor and 39/104
(37.5%) had a 9/10 HLA matched donor.
Biol Blood Marrow Transplant 17:1612-1618, 2011 1617Estimate of Unrelated Donor Search Outcomerise to 2 equilibrated 4-digit haplotypes. Based on this
observation, we hypothesized that broad haplotypes
with sufficient frequency that split into #2 4-digit
haplotypes could classify a recipient into a high
probability group. In agreement, carriage by the
patients of the predominant 4-digit haplotypes (n 5
50) from 45 broad haplotypes with frequencies
$0.19% improved (P \ 5  1026) the chance of
successful donor search.
Since 2002, Tiercy et al. [24] included in the esti-
mation process the frequencies of patientsHLA alleles,
B/C haplotypes, and DRB1/DQB1 haplotypes. Our
study provides evidence that rare alleles do not pre-
clude a successful search when carried by haplotypes
with sufficient frequencies. As an example, for 1 patient
with the common 4-digit haplotype A*02:05/B*50:01/
C*06:02/DRB1*07:01/DQB1*02:02, 5 of 7 donors
who were HLA-subtyped also carried the HLA-
A*0205 rare allele. All 5 were $9/10 HLA-matched.
In a more recent German study, the probability of
finding a suitable unrelated donor was predicted on
the basis of the patients, HLA-DRB1 alleles and
DRB1/DQB1 haplotype frequencies. In this study,
HLA-A/B/C high-resolution typing of the patient
was not considered in the probability estimation, con-
sidering the lower diversity of HLA-A and HLA-B al-
leles within broad Ag specificity groups in Caucasians
and because HLA-C matching was not included in
HLAcompatibility assessment in all patients. As shown
in Table 1, the highest rate of incompatibilities indeed
occurred at theHLA-DRB1 andDQB1 loci. It is worth
noticing, however, that incompatibilities could also in-
volve the class I loci. A hierarchy in HLA-C.HLA-A
or -B mismatches was observed. As suggested in the
German study, our results support that adding at least
the option of HLA-C compatibility could improve
their prediction strategy.With this approach, however,
the 4-digit common haplotypes that express the rare
DRB1*15:02 (n 5 2), *04:04 (n 5 1), *01:02 (n 5 1),
and *01:03 (n5 1) alleles in Table 1 would classify pa-
tients into a low probability group. Knowledge of the
common 4-digit haplotypes could instead classify these
patients into a high probability group. In agreement for
1 patient with the common haplotype A*01:01/
B*52:01/C*12:02/DRB1*15:02/DQB1*06:02, 3 of 3registry donors sharing 6 of 6 HLA identities with
the patient who was subtyped carried the HLA/
DRB1*15:02 allele. Again, all 3 were $9/10 HLA-
matched with the patient.
Finally, we want to emphasize that the associations
between DRB1*04:01 or DRB1*07:01 and various
DQB1* alleles greatly varied from 1 haplotype to an-
other. Consequently, a patient who expresses A30/
B13/DRB1*07:01/DQB1*03:03 would be classified
into the frequent probability group by the German
strategy. The probability of finding a donor in that
case would be low because HLA-DRB1*07:01 is asso-
ciated with DQB1*02:02 but not with DQB1*03:03 on
this haplotype (nb 13 in Table 1).
Although of interest, the use of the 4-digit com-
mon haplotypes listed herein will have limitations for
minority ethnic groups for 2 reasons. First, as exempli-
fied for NAC, these haplotypes are less frequent in mi-
nority ethnic groups. Second, rare associations of
alleles on the second haplotype will be more frequency
observed, as exemplified for 3 of 3 patients with no do-
nor found while expressing 1 common 4-digit haplo-
type (see Table 2).
Based on our data, we now classify our patients in
need for a $9/10 HLA-matched donor into 2 proba-
bility groups with a 98% and a 26% chance of finding
a donor, respectively. As both 10/10 and 9/10 HLA-
matched donors are considered suitable in our pediat-
ric center, this estimation process will, of course, have
limitations for centers with current standards requir-
ing only 10/10HLA-matches. As indicated in the foot-
note of Table 4, a majority of recipients in the high
probability group had a 10/10 HLA-matched donor.
Thus, including the 50 common adapted to their cur-
rent process could likely help these centers also.
In conclusion, several approaches have been pro-
posed to improve the estimate of search outcome.
Each of these has advantages and limitations. Rather
than being considered competing alternatives, they
should be regarded as complementary options. The
choice of the strategy could indeed depend on various
factors related, for example, to the geographic origin of
the patient, the level of HLA-matching required, or
other factors related to the transplant centers.ACKNOWLEDGMENTS
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